Stockscreener 앱 받기
1.585
4.28%
0.065
시장 영업 전:
1.65
0.065
+4.10%
Aldeyra Therapeutics Inc 주식(ALDX)의 최신 뉴스
Aldeyra Therapeutics Inc (ALDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BlackRock (ALDX holder) discloses 1.7% Aldeyra Therapeutics stake in amended 13G - Stock Titan
Aldeyra Therapeutics Inc (ALDX) Institutional Confidence - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Aldeyra Therapeutics Inc (ALDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aldeyra Therapeutics Inc (ALDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aldeyra Therapeutics, Inc. Revenue Breakdown – NASDAQ:ALDX - TradingView
ALDX|Aldeyra Therapeutics Inc|Price:1.520|Chg%:-0.030 - TradingKey
Aldeyra Therapeutics Inc (ALDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aldeyra Therapeutics Inc (ALDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aldeyra Therapeutics Inc (ALDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALDX Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Aldeyra Therapeutics Inc (ALDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out - ACCESS Newswire
Price to sales forward of Aldeyra Therapeutics, Inc. – FWB:137 - TradingView
Revenue per share of Aldeyra Therapeutics, Inc. – FWB:137 - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | NDAQ:ALDX | Press Release - Stockhouse
Aldeyra Therapeutics Inc. (ALDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Aldeyra Therapeutics to seek Type D meeting with FDA on reproxalap NDA resubmission - TradingView
Aldeyra Therapeutics (NASDAQ: ALDX) advances FDA dialogue on reproxalap NDA - Stock Titan
Understanding the Setup: (ALDX) and Scalable Risk - Stock Traders Daily
ALDX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - AOL.com
Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL (NASDAQ:ALDX) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Connect - ACCESS Newswire
ALDX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - AOL.com
ALDX Shareholder Alert: Aldeyra Therapeutics, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - AOL.com
Aldeyra Therapeutics (ALDX) Posts Modest Gain Amid Biotech Sector RecoveryReversal Setup Alerts - DonanımHaber
Levicept Ltd (ALDX) Appoints Darlene Deptula-Hicks as CFO Amid P - GuruFocus
Levicept Appoints Darlene Deptula-Hicks as CFO - GlobeNewswire Inc.
Aldeyra Therapeutics Q1 2026 Earnings: Narrower Loss Beats Estimates, Pipeline Progress Remains Key - DonanımHaber
Why Did ALDX Stock Tank 70% Today? - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - Sahm
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Aldeyra Therapeutics, Inc. Actuals & Estimates (TRADEGATE:137) - TradingView
ALDX News | ALDEYRA THERAPEUTICS INC (NASDAQ:ALDX) - ChartMill
The Technical Signals Behind (ALDX) That Institutions Follow - Stock Traders Daily
ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics - The National Law Review
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
Aldeyra Therapeutics (ALDX) Edges Higher Near Support; Key Resistance AheadETF Outflow Streak - dars.gov.et
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Value Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Dynamic Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000E Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Completeness Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2500 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Index - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
137 Forecast — Price Target — Prediction for 2027 - TradingView
Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Price to book forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView
1.97%
0.83%
자본화:
|
볼륨(24시간):